PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.](https://figures.cochat.ai/paper-figures/17d4ebdc4d0a46a99e4bb1385a64faa3/pink1-protects-against-oxidative-stress-by-phosphorylating-mitochondrial-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 1×
“Biochemical assays of cytochrome c release were performed as described [40].”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“served serine/threonine kinase domain [5].”
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Postmortem analyses reveal a deficiency in the mitochondrial complex I function in patients with sporadic PD [3].”
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“loss of PINK1 leads to mitochondrial defects and degeneration of muscle and dopaminergic neurons [”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“dopaminergic neurons [17–20].”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“In vitro kinase assays were performed as described [33] by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with TRAP1 for 20 min at 30 8C in 100 ll of reaction buffer containing 50 mM Tris-HCl (pH 7.”
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116 · cited 1×
“PC12 cells were treated with H2O2 as indicated, and cell viability was assessed using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described [38].”
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 1×
“of cellular processes, including cell survival and apoptosis [24, 25 ].”
Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.-W., Yang, L., Beal, M. F., Vogel, H., & Lu, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602493103 · Cited by 798 · cited 1×
“dopaminergic neurons [17–20].”
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 753
Genetics of Parkinson disease: paradigm shifts and future prospects
Farrer, M. J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1831 · Cited by 707 · cited 1×
“Genetic studies have identified a number of genes associated with familial PD [2].”
Animal models of Parkinson's disease
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 592
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581 · cited 1×
“For cell-based assays of cytochrome c release, the cellular distribution of cytochrome c was determined by immunofluorescence confocal microscopy using anticytochrome c antibody (clone 6H2.B4, BD Biosciences) as described [ 41 ].”
Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568 · cited 1×
“Protein bands were excised from the membrane, digested by trypsin, and analyzed by nanoelectrospray tandem mass spectrometry as described previously [30,31].”
Self-citationOxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases
Choi, J., Sullards, M. C., Olzmann, J. A., Rees, H. D., Weintraub, S. T., Bostwick, D. E., Gearing, M., Levey, A. I., Chin, L.-S., & Li, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509079200 · Cited by 483 · cited 1×
“Protein bands were excised from the membrane, digested by trypsin, and analyzed by nanoelectrospray tandem mass spectrometry as described previously [30,31].”
Self-citationMitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism
Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccola, B., Valente, E. M., & Casari, G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi377 · Cited by 450 · cited 4×
“For example, analyses with recombinant GST-fused PINK1 proteins purified from Escherichia coli showed that PINK1 autophosphorylation activity was slightly decreased by the G309D mutation [11,12] and was significantly increased by the W437X mutation [12] and that neither of these mutations affected the activity of PINK…”
InfluentialBeere, H. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26471 · Cited by 414 · cited 1×
“of cellular processes, including cell survival and apoptosis [ 24 ,25].”
Beilina, A., Van Der Brug, M., Ahmad, R., Kesavapany, S., Miller, D. W., Petsko, G. A., & Cookson, M. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500617102 · Cited by 381 · cited 4×
“Computer modeling analysis of the PINK1 kinase domain suggests that the amino acid residues K219, D362, and D384 might be key determinants of PINK1 catalytic activity [11].”
InfluentialThe hsp90-related Protein TRAP1 Is a Mitochondrial Protein with Distinct Functional Properties
Felts, S. J., Owen, B. A. L., Nguyen, P., Trepel, J., Donner, D. B., & Toft, D. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3305 · Cited by 370 · cited 2×
“PINK1 and TRAP1 both contain a predicted mitochondria targeting signal at their N-terminus, and a mitochondrial localization has previously been reported for PINK1 [12] as well as for TRAP1 [ 23 ].”
Hovius, R., Lambrechts, H., Nicolay, K., & de Kruijff, B. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90036-n · Cited by 353 · cited 1×
“tion, mitochondria isolated from PC12 cells were further separated by differential centrifugation into the matrix, the inner mitochondrial membrane, the intermembrane space, and the outer mitochondrial membrane fractions as described [36].”
PINK1 protein in normal human brain and Parkinson's disease
Gandhi, S. (2006) · Brain · doi:10.1093/brain/awl114 · Cited by 342 · cited 1×
“been shown to localize in the mitochondria [5,11–13] and”
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., De Mari, M., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338
Petit, A., Kawarai, T., Paitel, E., Sanjo, N., Maj, M., Scheid, M., Chen, F., Gu, Y., Hasegawa, H., Salehi-Rad, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505143200 · Cited by 329 · cited 1×
“sion of wild-type PINK1 protects cells against apoptotic stimuli [5,15], whereas small interfering RNA (siRNA)–”
Chen, J., Fujii, K., Zhang, L., Roberts, T., & Fu, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141224398 · Cited by 316 · cited 1×
“Apoptotic cell death was measured by morphological assessment of nuclei stained with 49,6-diamidino-2-phenylindole (DAPI, Molecular Probes) as previously described [39].”
Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function
Olzmann, J. A., Brown, K., Wilkinson, K. D., Rees, H. D., Huai, Q., Ke, H., Levey, A. I., Li, L., & Chin, L.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311017200 · Cited by 267 · cited 1×
“Conventional molecular biological techniques [28] were used to generate the C-terminally FLAGtagged human PINK1 (PINK1-FLAG), the PD-linked G309D, W437X, and L347P mutant PINK1, and the putative catalytically inactive PINK1 mutants, K219A, D362A, D384A, and the KDD triple mutant.”
Self-citationSong, H. Y., Dunbar, J. D., Zhang, Y. X., Guo, D., & Donner, D. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3574 · Cited by 264 · cited 1×
“Mass spectrometry analysis unambiguously identified the 75-kDa PINK1-associated protein as TRAP1, a ubiquitously expressed protein with significant sequence homology to the HSP90AA1 family of molecular chaperones [21–23].”
Novel PINK1 mutations in early‐onset parkinsonism
Hatano, Y., Li, Y., Sato, K., Asakawa, S., Yamamura, Y., Tomiyama, H., Yoshino, H., Asahina, M., Kobayashi, S., Hassin‐Baer, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20251 · Cited by 245 · cited 2×
“These results suggest a dominant negative pathogenic mechanism by which heterozygous PINK1 mutations lead to Parkinsonian symptoms [6,7,9].”
Novel PINK1 mutations in early-onset parkinsonism
波田野, 靖. (2005) · Medical Entomology and Zoology · Cited by 227
Antioxidants protect PINK1 -dependent dopaminergic neurons in Drosophila
Wang, D., Qian, L., Xiong, H., Liu, J., Neckameyer, W. S., Oldham, S., Xia, K., Wang, J., Bodmer, R., & Zhang, Z. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604661103 · Cited by 197 · cited 1×
“dopaminergic neurons [17–20].”
Hrs Interacts with Sorting Nexin 1 and Regulates Degradation of Epidermal Growth Factor Receptor
Chin, L.-S., Raynor, M. C., Wei, X., Chen, H.-Q., & Li, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004129200 · Cited by 191 · cited 3×
“com) gradient as described previously [32].”
Self-citationChen, C.-F., Chen, Y., Dai, K., Chen, P.-L., Riley, D. J., & Lee, W.-H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4691 · Cited by 182
Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y
Deng, H., Jankovic, J. J., Guo, Y., Xie, W., & Le, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.178 · Cited by 175 · cited 1×
“mediated depletion of PINK1 increases the susceptibility to apoptotic cell death [16].”
Sim, C. H., Lio, D. S. S., Mok, S. S., Masters, C. L., Hill, A. F., Culvenor, J. G., & Cheng, H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl398 · Cited by 147 · cited 1×
“In contrast, a recent study using recombinant PINK1 proteins isolated from baculovirusinfected sf9 insect cells failed to detect PINK1 autophosphorylation activity, but showed that PINK1 C-terminal truncation reduced the activity of PINK1 to phosphorylate artificial substrate histone H1 [27].”
Masuda, Y., Shima, G., Aiuchi, T., Horie, M., Hori, K., Nakajo, S., Kajimoto, S., Shibayama‐Imazu, T., & Nakaya, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404256200 · Cited by 142 · cited 1×
“VP16 [26].”
Hedrich, K., Hagenah, J. M., Djarmati, A., Hiller, A., Lohnau, T., Lasek, K., Grünewald, A., Hilker, R., Steinlechner, S., Boston, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.833 · Cited by 133 · cited 1×
“These results suggest a dominant negative pathogenic mechanism by which heterozygous PINK1 mutations lead to Parkinsonian symptoms [6,7,9].”
Carl, S., Gillete-Ferguson, I., & Ferguson, D. G. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.8.7687266 · Cited by 114 · cited 1×
“Double labeling indirect immunofluorescence microscopy was performed as described previously [29,34,35].”
SNIP, a Novel SNAP-25-interacting Protein Implicated in Regulated Exocytosis
Chin, L., Nugent, R. D., Raynor, M., Vavalle, J. P., & Li, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1191 · Cited by 112 · cited 2×
“A polyclonal anti-PINK1 antibody was raised in rabbit against amino acids 135–155 of human PINK1, and affinity purified as described previously [29].”
Self-citationLi, Y., Chin, L., Levey, A. I., & Li, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111612200 · Cited by 98 · cited 1×
“Double labeling indirect immunofluorescence microscopy was performed as described previously [29,34,35].”
Self-citationNakajima, A., Kataoka, K., Hong, M., Sakaguchi, M., & Huh, N.-H. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00443-9 · Cited by 64 · cited 1×
“exhibit autophosphorylation activity in vitro [11,12,14].”
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism
Criscuolo, C., Volpe, G., Rosa, A. D., Varrone, A., Marongiu, R., Mancini, P., Salvatore, E., Dallapiccola, B., Filla, A., Valente, E. M., et al. (2006) · Movement Disorders · doi:10.1002/mds.20933 · Cited by 49 · cited 2×
“early-onset PD, a number of heterozygous mutations affecting only one PINK1 allele have been associated with late-onset PD [6–10].”
GRIF1 binds Hrs and is a new regulator of endosomal trafficking
Kirk, E., Chin, L., & Li, L. (2006) · Journal of Cell Science · doi:10.1242/jcs.03249 · Cited by 42 · cited 1×
“PC12 cells were transfected with the indicated siRNAs using the TransIT siQUEST (Mirus) reagent as described previously [37].”
Self-citationZadikoff, C., Rogaeva, E. A., Djarmati, A., Sato, C., Salehi‐Rad, S., George‐Hyslop, P. S., Klein, C., & Lang, A. E. (2006) · Movement Disorders · doi:10.1002/mds.20854 · Cited by 33 · cited 2×
“early-onset PD, a number of heterozygous mutations affecting only one PINK1 allele have been associated with late-onset PD [6–10].”
Research works printed but not linked: 41
- Lang, 1998, N Engl J Med, 339, 1044
- Farrer, 2006, Nat Rev Genet, 7, 306
- Schapira, 1989, Lancet, 1, 1269
- Betarbet, 2002, Bioessays, 24, 308
- Valente, 2004, Science, 304, 1158
- Hatano, 2004, Ann Neurol, 56, 424
- Bonifati, 2005, Neurology, 65, 87
- Zadikoff, 2006, Mov Disord, 21, 875
- Hedrich, 2006, Arch Neurol, 63, 833
- Criscuolo, 2006, Mov Disord, 21, 1265
- Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
- Silvestri, 2005, Hum Mol Genet, 14, 3477
- Gandhi, 2006, Brain, 129, 1720
- Nakajima, 2003, Cancer Lett, 201, 195
- Petit, 2005, J Biol Chem, 280, 34025
- Deng, 2005, Biochem Biophys Res Commun, 337, 1133
- Clark, 2006, Nature, 441, 1162
- Park, 2006, Nature, 441, 1157
- Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
- Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
- Song, 1995, J Biol Chem, 270, 3574
- Chen, 1996, Mol Cell Biol, 16, 4691
- Felts, 2000, J Biol Chem, 275, 3305
- Beere, 2005, J Clin Invest, 115, 2633
- Muchowski, 2005, Nat Rev Neurosci, 6, 11
- Masuda, 2004, J Biol Chem, 279, 42503
- Sim, 2006, Hum Mol Genet, 15, 3251
- Olzmann, 2004, J Biol Chem, 279, 8506
- Chin, 2000, J Biol Chem, 275, 1191
- Choi, 2004, J Biol Chem, 279, 13256
- Choi, 2006, J Biol Chem, 281, 10816
- Chin, 2001, J Biol Chem, 276, 7069
- Ninomiya-Tsuji, 1999, Nature, 398, 252
- Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
- Li, 2002, J Biol Chem, 277, 28212
- Hovius, 1990, Biochim Biophys Acta, 1021, 217
- Kirk, 2006, J Cell Sci, 119, 4689
- Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
- Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
- Yang, 1997, Science, 275, 1129
- Sherer, 2002, J Neurosci, 22, 7006
Cited by
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
“Omi/HtrA2, a serine protease, and tumor necrosis factor receptor-associated protein 1 (TRAP-1), a chaperone protein, both have been reported to be targets of PINK1 (Plun-Favreau et al., 2007; Pridgeon et al., 2007).”
BackgroundHSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL
Jin, S. M., Lazarou, M., Wang, C., Kane, L. A., Narendra, D. P., & Youle, R. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201008084 · Cited by 1,375
“Finally, in some studies, PINK1 has been localized to the inner membrane with its kinase domain facing the intermembrane space (Silvestri et al., 2005; Plun-Favreau et al., 2007; Pridgeon et al., 2007).”
BackgroundMitochondria in neuroplasticity and neurological disorders
Mattson, M. P., Gleichmann, M., & Cheng, A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.010 · Cited by 1,081
Metadata
- Authors
- Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Chin, Lih-Shen
- Li, Lian
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-06-19
- Volume
- 5
- Issue
- 7
- Pages
- e172
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC1892574
- OpenAlex
- W2055538245
- Cited by
- 596
- References
- 44
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
- FWCI
- 42.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG021489, R01AG021489)
- National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.